This Article Full Text (OnlineFirst PDF) All Versions of this Article: 1087057108323126v1 13/8/817    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Ferraz, R. M. Articles by Villaverde, A. Search for Related Content PubMed PubMed Citation Articles by Ferraz, R. M. Articles by Villaverde, A. Pubmed/NCBI databases Substance via MeSH Social Bookmarking                         What's this?

Antiretroviral Therapy-Induced Functional Modification of IgG4 and IgM Responses in HIV-1–Infected Individuals Screened by an Allosteric Biosensor

^* To whom correspondence should be addressed. E-mail: avillaverde{at}servet.uab.es.

	Abstract

We have explored the effect of antiretroviral drugs on the antiviral immune response in human immunodeficiency virus-1 (HIV1)–infected patients by using an enzymatic immunosensor that detects epitope-modifying anti-gp41 antibodies. By this molecular sensing approach, we have identified an irreversible impact of drug administration on the functionality of IgG4 and IgM specific antibodies regarding the structural modification promoted on their target epitope. During the antiretroviral therapy, the prevalent induced fit promoted by IgM on the epitope was lost at the expense of that promoted by IgG4, suggesting alternative-ness in the neutralization potency of these antibody subpopulations. Because the particular drug composition of the antiretroviral treatment did not affect such immune shift, the obtained data strongly suggest that the drop in the viral load and the consequent lost of antigenemia are responsible for the functional adaptation observed in the humoral response. (Journal of Biomolecular Screening XXXX:xx-xx)

First published on August 15, 2008, doi:10.1177/1087057108323126

Journal of Biomolecular Screening 2008;13:817.

A more recent version of this article appeared on September 1, 2008


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M. T. Sanchez-Aparicio, M. F. Rosas, R. M. Ferraz, L. Delgui, J. J. Veloso, E. Blanco, A. Villaverde, and F. Sobrino Discriminating Foot-and-Mouth Disease Virus-Infected and Vaccinated Animals by Use of {beta}-Galactosidase Allosteric Biosensors Clin. Vaccine Immunol., August 1, 2009; 16(8): 1228 - 1235. [Abstract] [Full Text] [PDF]